All In MedTech

FDA Clearance Tracker · P800036-S041

INFUSAID Implantable Infusion Pump and Accessories

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 7, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 7, 2020

Approved

Time to decision

29 days

Received Jan 9, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P800036-S041
Device name
INFUSAID Implantable Infusion Pump and Accessories
Applicant location
Wellesley, MA
Received
Jan 9, 2020
Decided
Feb 7, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P800036

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Intera Oncology, Inc., 65 William Street, Suite 200, Wellesley, Massachusetts, to conduct quality system activities.

Source documents

Other decisions for Intera Oncology

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.